Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 8.21 is 49% above its 5-year average of 5.49, around the middle of its 5-year range (1.84–20.31).
As of the fiscal period ended Tuesday, June 30, 2026. 1.06% below its 12-month average of 8.29.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 8.21.
QUICK RATIO (ACID-TEST)
8.21
QUICK RATIO (ACID-TEST) AVG TTM
8.29
QUICK RATIO (ACID-TEST) AVG 3Y
5.52
QUICK RATIO (ACID-TEST) AVG 5Y
5.49
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-1.06%
CURRENT VS 3Y AVG
+48.77%
CURRENT VS 5Y AVG
+49.36%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
2.99
median of 635 covered companies
CURRENT VS SECTOR MEDIAN
+174.44%
vs the sector median at left
Market Cap
$13.72M
Quick Ratio (Acid-Test)
4.37
TTM Avg
1.21
3Y Avg
1.25
5Y Avg
1.53
Market Cap
$14.01M
Quick Ratio (Acid-Test)
0.40
TTM Avg
0.15
3Y Avg
4.02
5Y Avg
6.30
Market Cap
$13.10M
Quick Ratio (Acid-Test)
0.50
TTM Avg
1.75
3Y Avg
2.03
5Y Avg
3.39
Market Cap
$13.25M
Quick Ratio (Acid-Test)
1.69
TTM Avg
0.14
3Y Avg
1.07
5Y Avg
2.78
Market Cap
$12.86M
Quick Ratio (Acid-Test)
6.66
TTM Avg
2.77
3Y Avg
1.93
5Y Avg
5.53
Market Cap
$14.39M
Quick Ratio (Acid-Test)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$14.56M
Quick Ratio (Acid-Test)
0.76
TTM Avg
1.36
3Y Avg
2.82
5Y Avg
3.25
Market Cap
$12.44M
Quick Ratio (Acid-Test)
0.99
TTM Avg
0.99
3Y Avg
1.05
5Y Avg
1.43
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| IN8bio, Inc. (INAB) | $13.62M | 8.21 | 8.29 | 5.52 | 5.49 |
| Vyome Holdings, Inc. (HIND)vs › | $13.72M | 4.37 | 1.21 | 1.25 | 1.53 |
| Citius Pharmaceuticals, Inc. (CTXR)vs › | $14.01M | 0.40 | 0.15 | 4.02 | 6.30 |
| Cytosorbents Corporation (CTSO)vs › | $13.10M | 0.50 | 1.75 | 2.03 | 3.39 |
| Optimi Health Corp. (OPTH)vs › | $13.25M | 1.69 | 0.14 | 1.07 | 2.78 |
| Cellectar Biosciences, Inc. (CLRB)vs › | $12.86M | 6.66 | 2.77 | 1.93 | 5.53 |
| Obsidian Therapeutics Inc. (OBX)vs › | $14.39M | N/A | N/A | N/A | N/A |
| Karyopharm Therapeutics Inc. (KPTI)vs › | $14.56M | 0.76 | 1.36 | 2.82 | 3.25 |
| Dare Bioscience, Inc. (DARE)vs › | $12.44M | 0.99 | 0.99 | 1.05 | 1.43 |
| IRIDEX Corporation (IRIX)vs › | $12.17M | 1.08 | 1.32 | 1.15 | 1.64 |
Quick Ratio
8.21
Excludes inventory
Current Ratio
8.21
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 8.21 |
| 2026-03-31 | 10.50 |
| 2025-12-31 | 8.82 |
| 2025-09-30 | 6.91 |
| 2025-06-30 | 7.03 |
| 2025-03-31 | 4.30 |
| 2024-12-31 | 4.08 |
| 2024-09-30 | 1.84 |
| 2024-06-30 | 2.66 |
| 2024-03-31 | 4.10 |
| 2023-12-31 | 4.57 |
| 2023-09-30 | 3.53 |
| 2023-06-30 | 5.15 |
| 2023-03-31 | 3.84 |
| 2022-12-31 | 3.82 |
| 2022-09-30 | 6.05 |
| 2022-06-30 | 9.08 |
| 2022-03-31 | 16.09 |
| 2021-12-31 | 17.28 |
| 2021-09-30 | 20.31 |
| 2021-06-30 | 4.39 |
| 2021-03-31 | 5.02 |
| 2020-12-31 | 7.05 |
| 2020-09-30 | 0.00 |
| 2020-06-30 | 1.78 |
| 2020-03-31 | 0.00 |
| 2019-12-31 | 1.18 |
| 2019-09-30 | 1.18 |
| 2019-06-30 | 0.00 |
| 2019-03-31 | 0.00 |
| 2018-06-30 | 0.00 |
| 2018-03-31 | 0.00 |
